390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection

BACKGROUND: Eravacycline (ERV) is a fluorocycline with in vitro activity against Clostridioides difficile infection (CDI). The purpose of this study was to evaluate the usage of ERV in the management of CDI. METHODS: IRB-approved, retrospective case series in a health system that added ERV to formul...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Austin R, Kwiatkowski, Shaina, Ramesh, Mayur, Kenney, Rachel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752416/
http://dx.doi.org/10.1093/ofid/ofac492.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752416/
http://dx.doi.org/10.1093/ofid/ofac492.468

Ejemplares similares